The Limited Times

Now you can see non-English news...

"A safe and effective vaccine": the European Medicines Agency reassures on AstraZeneca

2021-03-18T16:34:40.707Z


The British-Swedish vaccine, suspended since Monday in several countries of the European Union including France due to rare cases of throm


Will the AstraZeneca vaccine find its way back to vaccination centers in Europe, and more particularly in France?

Long-awaited, the opinion of the European Medicines Agency (EMA) has in any case been issued this Thursday afternoon: without clearly giving the green light to the Swedish-British vaccine on the European market, the agency ensures that it is a "safe and effective" vaccine.

An investigation will still be launched into the rare cases that have been reported and the risk will be mentioned to professionals and patients in the brochures provided to them.

“We cannot exclude a link between the formation of blood clots and the vaccine,” explained Emer Cooke, director of the EMA, who however explains that the risk-benefit is largely favorable.

AstraZeneca had been suspended by several countries of the European Union, including France since Monday, due to complications - thrombosis and difficulty in coagulating - observed in rare patients.

The decision to administer or not doses of the AstraZeneca vaccine to their nationals will therefore be up to the States.

France should take a position this Thursday evening, on the occasion of the press conference planned by Jean Castex and Olivier Véran.

READ ALSO>

Covid-19: follow our direct

The EMA's announcement comes at a crucial time for the European Union which, in the midst of a vaccine shortage, relies on millions of doses from the Nordic laboratory.

The European agency gave the green light on January 29 to this vaccine developed by the Swedish-British laboratory AstraZeneca and the University of Oxford.

WHO had recommended it

The EMA is in line with the World Health Organization (WHO), which on Wednesday recommended to continue using it.

"For the moment, the risk / benefit balance tilts in favor of the AstraZeneca vaccine," said the UN organization.

Emer Cooke said on Wednesday that she was "firmly convinced" that the benefits of the vaccine outweigh the risks.

If the latter had not ruled out that the EMA suspends the AstraZeneca vaccine in the EU in the event of a problem that cannot be resolved, it also speculated that it would only publish an “additional warning” concerning these complications.

READ ALSO>

Vaccine delivery delays: Europe must "show its fangs", launches Castex

Coronavirus Newsletter

Update on the Covid-19 epidemic

Subscribe to the newsletterAll newsletters

Evidence for many countries engaged in a real race against time with the virus, including France, faced with an upsurge in contamination in Paris and the Paris region.

To help restore confidence in a vaccine which, according to a survey, is only considered reliable by 22% of French people, Prime Minister Jean Castex said he was ready to be vaccinated as soon as it is re-authorized.

Source: leparis

All life articles on 2021-03-18

You may like

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.